Kensing, LLC (Kankakee, Ill.; www.kensingsolutions.com), a leading manufacturer of natural vitamin E, plant sterols, specialty esters and high-purity anionic surfactants, and a portfolio company of One Rock Capital Partners, LLC, today announced that it has entered into a definitive agreement to acquire the amphoteric surfactants and specialty esters manufacturing operations from Evonik Corp. (Essen, Germany; www.evonik.com)
Located in Hopewell, Virginia, the Evonik business that Kensing will acquire primarily serves the personal care market, with a focus on skin care, hair care and oral care applications.
“The amphoteric surfactants and specialty esters manufacturing operations that Kensing will acquire as a result of this transaction are complementary to our existing product portfolio derived from plant-based feedstocks,” said Serge Rogasik, CEO of Kensing.
The transaction is subject to regulatory approvals and customary closing conditions and is expected to close in the third quarter of 2022.